MedImmune Vaccines, Inc. Creates New Long-Term Strategic Planning Post

GAITHERSBURG, Md., June 12 /PRNewswire-FirstCall/ -- MedImmune, Inc. (Nasdaq: MEDI - News) today announced that Sidney Mazel, Ph.D. has joined the management team as senior vice president, product planning and portfolio management. In this newly created position, Dr. Mazel will lead the life-cycle management of the company's expanding portfolio of products and product candidates. Specifically, he will be responsible for new product planning, project management, market research and competitive intelligence.
MORE ON THIS TOPIC